Arie Zauberman

752 citations
9 papers · 560 indexed · h-index 9
Topics
Hepatitis B Virus Studies (4 papers)Cancer-related Molecular Pathways (3 papers)Hepatitis C virus research (3 papers)
Partner nations
IsraelAustraliaSweden

In The Last Decade

Arie Zauberman

9 papers receiving 547 citations

Peers

Arie Zauberman
Comparison fields: 5 of 56
  • Molecular Biology 314
  • Oncology 295
  • Epidemiology 172
  • Hepatology 149
  • Biotechnology 73
Replace Hélène Mouly with:
Hélène Mouly France
Ken Kuramoto Japan
Jennifer MacGregor United States
Takemi Sakamoto Japan
Thomas L. Haulk United States
Andressa Ardiani United States
Philip R. Tempest United Kingdom
Giovanni Nitti United States
Shantha Senadheera United States
Christopher Alder United Kingdom
Arie Zauberman relative to Hélène Mouly France Hélène Mouly's profile →
Citations per field
00.5×4.9×
Hélène Mouly · 1×
Citations per year

Countries citing papers authored by Arie Zauberman

Since Specialization
Citations

This map shows the geographic impact of Arie Zauberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie Zauberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie Zauberman more than expected).

Fields of papers citing papers by Arie Zauberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arie Zauberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie Zauberman. The network helps show where Arie Zauberman may publish in the future.

Co-authorship network of co-authors of Arie Zauberman

This figure shows the co-authorship network connecting the top 25 collaborators of Arie Zauberman. A scholar is included among the top collaborators of Arie Zauberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arie Zauberman. Arie Zauberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 10
2 15
3 30
4 69
5
The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.
9
6 66
7 13
8 243
9 105

About Arie Zauberman

Arie Zauberman is a scholar working on Hepatology, Virology and Epidemiology, having authored 9 papers that have together received 560 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (4 papers), Cancer-related Molecular Pathways (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Hepatology (149 citations), Oncology (295 citations) and Biotechnology (73 citations). Arie Zauberman has collaborated with scholars based in Israel, Australia and Sweden. Frequent co-authors include Moshe Oren, Yaacov Barak, Deborah A. Flusberg, Ygal Haupt, Doron Ginsberg, Eitan Shaulian, Shlomo Dagan, Ofer Nussbaum, Ehud Ilan and Rachel Eren. Their work appears in journals such as Nucleic Acids Research, Molecular and Cellular Biology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026